Advertisement
Screener

Creative Medical Technology Holdings, Inc. (CELZ) Graph

CELZ Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $0.00; Cost of revenue $0.00; Research and development $459.20K; Selling, general and administrative $1.08M.
  • 2026-03-31: Revenue $0.00; Cost of revenue $0.00; Research and development $541.66K; Selling, general and administrative $888.64K.
  • 2025-12-31: Revenue $3.00K*; Cost of revenue $994.00*; Research and development $550.08K*; Selling, general and administrative $1.37M*.
  • 2025-09-30: Revenue $0.00; Cost of revenue $0.00; Research and development $465.15K; Selling, general and administrative $776.82K.

Revenue flow

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

CELZ revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Revenue$0.00Cost of revenue$0.00Gross profit$0.00Operating expenses$1.56MOperating income-$1.56MResearch & development$459.20KSelling, general& administrative$1.08MPre-tax income-$1.51MIncome tax$0.00

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$0.00$0.00$459.20K$1.08M$1.56M$0.00-$1.51M
2026-03-31$0.00$0.00$541.66K$888.64K$1.46M$0.00-$1.41M
2025-12-31$3.00K*$994.00*$550.08K*$1.37M*$1.95M*$0.00*-$1.89M*
2025-09-30$0.00$0.00$465.15K$776.82K$1.27M$0.00-$1.24M
2025-06-30$0.00$0.00$501.26K$731.52K$1.26M$0.00-$1.23M
2025-03-31$3.00K$1.20K$743.30K$888.40K$1.66M$0.00-$1.64M
2024-09-30$0.00$0.00$581.80K$498.61K$1.11M$0.00-$1.04M
2024-06-30$8.00K$3.20K$924.75K$676.09K$1.63M$0.00-$1.56M
2024-03-31$0.00$0.00$422.39K$671.48K$1.12M$0.00-$1.04M
2023-09-30$6.00K$2.40K$992.72K$531.04K$1.55M$0.00-$1.45M
2023-06-30$0.00$0.00$309.48K$859.54K$1.19M$0.00-$1.10M
2023-03-31$0.00$0.00$319.03K$771.02K$1.11M$0.00-$1.05M
2022-09-30$55.00K$16.00K$230.94K$805.46K$1.06M$0.00-$982.34K
2022-06-30$0.00$0.00$659.70K$1.11M$1.79M$0.00-$1.79M
2022-03-31$15.00K$6.79K$10.00K$1.13M$1.16M$0.00-$1.15M
2021-09-30$10.00K$4.00K$59.18K$757.24K$839.44K$0.00-$1.84M
2021-06-30$10.00K$4.50K$0.00$498.32K$521.34K(m)-$2.91M
2021-03-31$0.00$0.00$0.00$280.92K$303.94K$0.00$27.84M
2020-09-30$77.00K$17.60K$0.00$285.10K$301.87K$0.00$394.85K
2020-06-30$27.90K$10.80K(m)$214.89K$231.36K(m)-$1.84M
2020-03-31$42.10K$14.20K(m)$346.17K$362.94K$0.00$3.74M
2019-09-30$57.50K$8.00K$0.00$317.64K$322.92K$0.00-$2.41M
2019-06-30$61.60K$19.20K$0.00$312.57K$317.86K$0.00-$88.23K
2019-03-31$50.80K$14.24K$0.00$281.97K$287.26K$0.00-$797.37K
2018-09-30$52.40K$36.40K$2.88K(m)$290.84K$0.00-$1.57M
2018-06-30$4.80K$2.53K$4.20K(m)$317.10K$0.00-$6.43M
2018-03-31$9.60K$2.40K$3.20K(m)$211.42K$0.00-$7.59M
2017-09-30$0.00$0.00$87.73K(m)$295.00K(m)-$52.18K
2017-06-30$0.00$0.00$25.19K(m)$395.99K(m)-$886.36K
2017-03-31$0.00$0.00$59.83K(m)$240.85K(m)-$243.35K
2016-09-30$0.00(m)$45.17K(m)$212.54K(m)-$214.51K
2016-06-30$0.00(m)$18.03K(m)$208.10K(m)-$209.25K
2016-03-31$0.00(m)$4.36K(m)$147.13K(m)-$147.84K
2015-12-31$0.00*(m)(m)(m)$6.34K*(m)-$8.92K*
2015-09-30$0.00(m)(m)(m)$3.73K(m)-$6.30K
2015-06-30$0.00(m)(m)(m)$3.77K(m)-$6.27K
2015-03-31$0.00(m)(m)(m)$6.99K(m)-$9.27K
2014-09-30$0.00(m)(m)(m)$3.55K(m)-$5.75K
2014-06-30$0.00(m)(m)(m)$3.63K(m)-$5.74K
2014-03-31$0.00(m)(m)(m)$8.04K(m)-$10.02K
2013-09-30$0.00(m)(m)(m)$3.60K(m)-$5.44K
2013-06-30$0.00(m)(m)(m)$3.99K(m)-$5.74K
2013-03-31$0.00(m)(m)(m)$8.45K(m)-$10.05K
2012-09-30$0.00(m)(m)(m)$4.08K(m)-$5.50K
2012-06-30$0.00(m)(m)(m)$3.69K(m)-$5.04K
2012-03-31$0.00(m)(m)(m)$7.81K(m)-$9.05K
2011-09-30$0.00(m)(m)(m)$3.50K(m)(m)
2011-06-30$0.00(m)(m)(m)$3.45K(m)(m)
2011-03-31$0.00(m)(m)(m)$7.27K(m)-$8.18K
2010-09-30$0.00(m)(m)(m)$2.77K(m)(m)
2010-06-30$0.00(m)(m)(m)$1.18K(m)(m)

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2026-06-30$0.00$0.00$1.00M$1.97M$3.02M$0.00-$2.92M
2025-06-30$3.00K$1.20K$1.24M$1.62M$2.93M$0.00-$2.87M
2024-06-30$8.00K$3.20K$1.35M$1.35M$2.75M$0.00-$2.60M
2023-06-30$0.00$0.00$628.51K$1.63M$2.31M$0.00-$2.15M
2022-06-30$15.00K$6.79K$669.70K$2.24M$2.95M$0.00-$2.95M
2021-06-30$10.00K$4.50K$0.00$779.24K$825.29K(m)$24.93M
2020-06-30$70.00K$25.00K(m)$561.05K$594.30K(m)$1.90M
2019-06-30$112.40K$33.44K$0.00$594.55K$605.12K$0.00-$885.60K
2018-06-30$14.40K$4.93K$7.40K(m)$528.52K$0.00-$14.02M
2017-06-30$0.00$0.00$85.02K(m)$636.84K(m)-$1.13M
2016-06-30$0.00(m)$22.39K(m)$355.23K$0.00-$357.09K
2015-06-30$0.00(m)(m)(m)$10.76K(m)-$15.54K
2014-06-30$0.00(m)(m)(m)$11.67K(m)-$15.76K
2013-06-30$0.00(m)(m)(m)$12.44K(m)-$15.79K
2012-06-30$0.00(m)(m)(m)$11.51K(m)-$14.09K
2011-06-30$0.00(m)(m)(m)$10.72K(m)-$12.65K
2010-06-30$0.00(m)(m)(m)$8.50K(m)(m)

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-09-30$3.00K$1.20K$1.71M$2.40M$4.20M$0.00-$4.11M
2024-09-30$8.00K$3.20K$1.93M$1.85M$3.86M$0.00-$3.64M
2023-09-30$6.00K$2.40K$1.62M$2.16M$3.85M$0.00-$3.61M
2022-09-30$70.00K$22.79K$900.63K$3.04M$4.01M$0.00-$3.93M
2021-09-30$20.00K$8.50K$59.18K$1.54M$1.66M$0.00$23.09M
2020-09-30$147.00K$42.60K$0.00$846.15K$896.17K$0.00$2.29M
2019-09-30$169.90K$41.44K$0.00$912.18K$928.04K$0.00-$3.29M
2018-09-30$66.80K$41.32K$10.28K(m)$819.36K$0.00-$15.59M
2017-09-30$0.00$0.00$172.75K(m)$931.84K(m)-$1.18M
2016-09-30$0.00(m)$67.57K(m)$567.77K(m)-$571.61K
2015-09-30$0.00(m)(m)(m)$14.49K(m)-$21.84K
2014-09-30$0.00(m)(m)(m)$15.23K(m)-$21.51K
2013-09-30$0.00(m)(m)(m)$16.04K(m)-$21.23K
2012-09-30$0.00(m)(m)(m)$15.59K(m)-$19.59K
2011-09-30$0.00(m)(m)(m)$14.21K(m)-$17.26K
2010-09-30$0.00(m)(m)(m)$11.27K(m)-$13.40K

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentSelling, general and administrativeOperating expensesIncome taxNet income
2025-12-31$6.00K$2.19K$2.26M$3.76M$6.15M$0.00-$6.00M
2024-12-31$11.00K$4.40K$2.40M$3.24M$5.75M$0.00-$5.49M
2023-12-31$9.00K$3.60K$1.97M$3.56M$5.63M$0.00-$5.29M
2022-12-31$88.60K$28.49K$6.27M$3.94M$10.30M$0.00-$10.14M
2021-12-31$87.75K$47.95K$109.18K$2.96M$3.17M$0.00$19.21M
2020-12-31$164.50K$50.60K$0.00$1.16M$1.23M$0.00-$36.33M
2019-12-31$165.50K$45.50K$0.00$1.22M$1.25M$0.00-$8.48M
2018-12-31$124.40K$70.38K$96.62K$1.05M$1.17M$0.00-$13.66M
2017-12-31$4.80K$8.00K$260.08K(m)$1.17M$0.00-$2.66M
2016-12-31$0.00$0.00$85.33K(m)$759.67K$0.00-$766.07K
2015-12-31$0.00(m)(m)(m)$20.83K$0.00-$30.76K
2014-12-31$0.00(m)(m)(m)$19.43K(m)-$28.01K
2013-12-31$0.00(m)(m)(m)$20.12K(m)-$27.28K
2012-12-31$0.00(m)(m)(m)$20.10K(m)-$25.59K
2011-12-31$0.00(m)(m)(m)$19.83K(m)-$24.05K
2010-12-31$0.00(m)(m)(m)$14.29K(m)-$17.26K

Similar stocks

Stock NameCountryMarket CapPE Ratio
AIM ImmunoTech Inc. (AIM)United States$0.006B
CERO THERAPEUTICS HOLDINGS, INC. (CERO)United States$0.007B
PharmaCyte Biotech, Inc. (PMCB)United States$0.005B
TScan Therapeutics, Inc. (TCRX)United States$0.008B-1.23
WINDTREE THERAPEUTICS INC /DE/ (WINT)United States$0.003B-0.32
VivoSim Labs, INC. (VIVS)United States$0.003B
Calidi Biotherapeutics, Inc. (CLDI)United States$0.003B
CURIS INC (CRIS)United States$0.002B-0.05
Senti Biosciences Holdings, Inc. (SNTI)United States$0.011B-0.70
Silexion Therapeutics Corp (SLXN)$0.001B